13F Holdings
中文EN

POSC POSITRON CORP

Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 844985 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin-572.6%
Operating margin-2,287.6%
Net margin-2,307.6%
FCF margin—
EBITDA margin-2,278.9%

Returns

ROE-2,479.9%
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets115.0%
Debt / equity—
Current ratio0.71x
Interest coverage-75.37x

Cash quality & payout

Operating cash flow / net income0.37x
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20142014-12-31FY20132013-12-31FY20122012-12-31
Income statement
Revenue$461,452$587,500$1.47M$1.63M$2.80M
Cost of revenue$2.58M$929,484$1.36M$1.21M$1.97M
Gross profit-$2.11M-$341,984$104,000$424,000$829,000
R&D expense——$471,000$564,000$940,000
SG&A expense$8.38M$1.86M$2.19M$2.78M$4.33M
Operating income-$10.50M-$2.21M-$2.74M-$3.34M-$4.72M
Interest expense$125,338$142,402$1.82M$2.14M$1.75M
Pretax income——-$2.58M-$7.10M-$7.96M
Income tax——$0$0$0
Net income-$10.60M-$2.38M-$2.58M-$7.10M-$7.96M
EBITDA-$10.47M-$2.18M-$2.59M-$3.18M-$4.50M
EPS (basic)-0.34-0.090.000.00-0.01
EPS (diluted)-0.34-0.090.000.00-0.01
Weighted avg. shares (diluted)30.89M25.98M3.70B1.45B1.27B
Banking
Deposits$375,000$375,000$10,000$18,000$53,000
Balance sheet
Cash & equivalents$2.52M$69,791$208,000$1.74M$243,000
Receivables$8,333$16,667$175,000$247,000$273,000
Inventory$680,000$1.26M$330,000$547,000$551,000
Current assets$3.34M$1.35M$730,000$2.57M$1.10M
PP&E, net$105,752$34,103$919,000$1.04M$1.17M
Goodwill——$0$0$346,000
Intangibles——$9,000$10,000$358,000
Total assets$4.00M$1.80M$1.87M$3.88M$2.69M
Current liabilities$2.40M$2.43M$2.70M$14.66M$8.11M
Short-term debt——$1.06M——
Long-term debt$153,686$24,302$1.07M—$689,000
Total debt$153,686$24,302$2.13M—$689,000
Total liabilities$2.56M$2.46M$2.71M$15.12M$8.88M
Shareholders' equity$1.44M-$656,725-$837,000-$11.24M-$6.19M
Net debt-$2.37M-$45,489$1.92M—$446,000
Shares outstanding32.80M27.31M13.89M1.45B1.45B
Cash flow statement
Operating cash flow-$4.70M-$1.73M-$2.42M-$3.05M-$2.24M
Capital expenditure——$26,000$16,000$73,000
Free cash flow——-$2.44M-$3.06M-$2.31M
Investing cash flow-$99,026—-$26,000-$16,000-$72,000
Financing cash flow$7.25M$1.70M$905,000$4.56M$2.55M
Depreciation & amortization$27,377$22,055$152,000$160,000$226,000
Stock-based compensation$4.98M—$89,000$656,000$1.78M

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.